.Zevra Therapeutics' unusual condition drug appears to become on the pathway to permission this fall...
.Pfizer's period 3 Duchenne muscle dystrophy (DMD) gene therapy failure has actually gone a $230 mil...
.After much more than two decades of deal with neurodegenerative health conditions, Swiss biotech AC...
.GSK has broken up a stage 2 individual papillomavirus (HPV) vaccination coming from its pipe after ...
.OS Therapies will detail on the NYSE American supply substitution today through a $6.4 million IPO ...
.ALX Oncology's period 2 gastric cancer cells feedback price has actually compromised. After viewing...
.An Additional of Ionis Pharmaceuticals' essential midphase readouts has disappointed desires, promp...
.While Biogen's pharma peers are actually hunting for late-stage possessions along with little bit o...
.Instil Biography has been a biotech trying to find a pipe after it ditched its lead resources over ...
.Biogen has handed back civil liberties to an early Alzheimer's ailment plan to Denali Rehabs, leavi...